Abelcet and Coma - a phase IV clinical study of FDA data

Summary:

Coma is reported as a side effect among people who take Abelcet (amphotericin b), especially for people who are female, 40-49 old, also take Acyclovir, and have Cryptococcosis.

The phase IV clinical study analyzes which people have Coma when taking Abelcet. It is created by eHealthMe based on reports of 849 people who have side effects when taking Abelcet from the FDA, and is updated regularly.

What is Abelcet?

Abelcet has active ingredients of amphotericin b. eHealthMe is studying from 853 Abelcet users. Check the latest studies of Abelcet.

What is Coma?

Coma (state of unconsciousness lasting more than six hours) is found to be associated with 2,892 drugs and 3,168 conditions by eHealthMe. Check the latest studies of Coma.

On Sep, 09, 2025

849 people reported to have side effects when taking Abelcet.
Among them, 17 people (2.0%) have Coma.

Among these 17 people:

What is the gender of people who have Coma when taking Abelcet? *

female: 52.94 %
male: 47.06 %

What is the age of people who have Coma when taking Abelcet? *

What are other drugs people take besides Abelcet? *

What are other side effects people have besides Coma? *

Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 6 people, 35.29%
Arrhythmias (irregular heartbeat): 4 people, 23.53%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 17.65%
Drowsiness: 3 people, 17.65%
Hepatic Failure (liver failure): 3 people, 17.65%
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 3 people, 17.65%
Acute Kidney Failure: 3 people, 17.65%
Fever: 3 people, 17.65%
Agitation (state of anxiety or nervous excitement): 3 people, 17.65%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 17.65%

What are the existing conditions these people have? *

Sedation: 2 people, 11.76%
Pain: 2 people, 11.76%
Cryptococcosis (potentially fatal fungal disease): 2 people, 11.76%
Sinusitis Fungal (fungal infection of sinus): 1 person, 5.88%
Fungal Infection: 1 person, 5.88%
Fever: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Abelcet and have Coma?

- Check whether Coma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abelcet:

Abelcet (853 reports)

Coma treatments and more:

Coma (57,420 reports)

Browse all side effects of Abelcet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Coma:

Coma (2,892 drugs)

Browse all the conditions that are associated with Coma:

Coma (3,168 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amphotericin b (the active ingredients of Abelcet) and Abelcet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.